Fund shareholders of Abbott Laboratories
ISIN US0028241000 · United States · LEI HQD377W2YR662HK5JX27
- Fund shareholders
- 1,129
- Of which ETFs
- 286 843 other funds
- Value held
- 54.7B $ 6.2B SEK · 53.7M €
- Share of capital
- 31.2 % of 1.7B shares on Jun 30, 2026
1,129 funds hold this company. This table lists the 1,122 that declare it in a regulatory filing. The other 7 publish their holdings in their own reports. They are not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| UBS PREMIUM MODERADO, FI UBS WEALTH MANAGEMENT, S.G.I.I.C., S.A. | 127.9K € | 0.31 % | as of Dec 31, 2025 ↗ | ||
| BBVA MEGATENDENCIA DEMOGRAFIA, FI BBVA ASSET MANAGEMENT, S.A., SGIIC | 127K € | 0.84 % | as of Dec 31, 2025 ↗ | ||
| FOMENTO DE AHORROS E INVERSIONES, SICAV, S.A. GESALCALA, S.A., S.G.I.I.C. | 124.4K € | 0.02 % | as of Dec 31, 2025 ↗ | ||
| DUX MIXTO MODERADO, FI ABANTE ASESORES GESTION, SGIIC, S.A. | 122K € | 0.34 % | as of Dec 31, 2025 ↗ | ||
| SWM GLOBAL FLEXIBLE,FI SINGULAR ASSET MANAGEMENT, SGIIC, S.A. | 106.7K € | 0.20 % | as of Dec 31, 2025 ↗ | ||
| SWM ESTRATEGIA RENTA VARIABLE,FI SINGULAR ASSET MANAGEMENT, SGIIC, S.A. | 106.7K € | 0.80 % | as of Dec 31, 2025 ↗ | ||
| GESIURIS MIXTO INTERNACIONAL FI GESIURIS ASSET MANAGEMENT, SGIIC, S.A. | 85.3K € | 0.40 % | as of Dec 31, 2025 ↗ | ||
| MARKET PORTFOLIO EQUITY, F.I. MARKET PORTFOLIO ASSET MANAGEMENT, S.G.I.I.C., S.A. | 77.9K € | 0.14 % | as of Dec 31, 2025 ↗ | ||
| INVERSIONES FINANCIERAS JUPEDAL, SICAV, SA SANTANDER ASSET MANAGEMENT, S.A., SGIIC | 76.9K € | 0.09 % | as of Dec 31, 2025 ↗ | ||
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 68.6K € | 1.87 % | as of Dec 31, 2025 ↗ | ||
| INVERVILLADA SICAV S.A. WELZIA MANAGEMENT, SGIIC, S.A. | 64K € | 2.21 % | as of Dec 31, 2025 ↗ | ||
| SIGLO XXI BOLSA, SICAV, S.A. UBS WEALTH MANAGEMENT, S.G.I.I.C., S.A. | 64K € | 0.84 % | as of Dec 31, 2025 ↗ | ||
| VALERIA VICTRIX INVERSIONES, SICAV, S.A. AMUNDI IBERIA, SGIIC, S.A. | 61.1K € | 0.31 % | as of Dec 31, 2025 ↗ | ||
| EMERITUS CAPITAL, SICAV, S.A. SINGULAR ASSET MANAGEMENT, SGIIC, S.A. | 53.3K € | 0.72 % | as of Dec 31, 2025 ↗ | ||
| ARPOADOR OCEANO DE INVERSIONES, SICAV S.A. SINGULAR ASSET MANAGEMENT, SGIIC, S.A. | 53.3K € | 0.99 % | as of Dec 31, 2025 ↗ | ||
| UBS PREMIUM DINÁMICO, FI UBS WEALTH MANAGEMENT, S.G.I.I.C., S.A. | 53.3K € | 0.87 % | as of Dec 31, 2025 ↗ | ||
| ATL CAPITAL CARTERA DINAMICA, FI ATL 12 CAPITAL GESTION S.G.I.I.C, S.A. | 48.5K € | 0.12 % | as of Dec 31, 2025 ↗ | ||
| TULIACAN, SICAV, S.A. ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 30.9K € | 0.39 % | as of Dec 31, 2025 ↗ | ||
| MONTE ESTORIL SICAV, S.A. AMUNDI IBERIA, SGIIC, S.A. | 22.2K € | 0.09 % | as of Dec 31, 2025 ↗ | ||
| DUX UMBRELLA, FI DUX UMBRELLA/ARAGUI-EGALA DUX INVERSORES, SGIIC, S.A. | 16.9K € | 0.54 % | as of Dec 31, 2025 ↗ | ||
| DUX UMBRELLA, FI DUX UMBRELLA/BOLSAGAR DUX INVERSORES, SGIIC, S.A. | 16.9K € | 0.79 % | as of Dec 31, 2025 ↗ | ||
| MULTIGESTION, FI MULTIGESTION/CASER GLOBAL OPCIONES INVERSIS GESTIÓN, S.A., SGIIC | 9.6K € | 0.40 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| iShares U.S. Medical Devices ETF iShares Trust | 16.98 % | as of Mar 31, 2026 ↗ |
| DIAMOND HILL LARGE CAP CONCENTRATED ETF Diamond Hill Funds | 5.58 % | as of Mar 31, 2026 ↗ |
| Select Medical Technology and Devices Portfolio Fidelity Select Portfolios | 4.88 % | as of Feb 28, 2026 ↗ |
| DIAMOND HILL SELECT FUND Diamond Hill Funds | 4.58 % | as of Mar 31, 2026 ↗ |
| DIAMOND HILL LARGE CAP FUND Diamond Hill Funds | 4.35 % | as of Mar 31, 2026 ↗ |
| Invesco Pharmaceuticals ETF Invesco Exchange-Traded Fund Trust | 4.20 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc. | 3.91 % | as of Mar 31, 2026 ↗ |
| Jensen Quality Growth ETF Trust for Professional Managers | 3.59 % | as of Feb 28, 2026 ↗ |
| AdvisorShares Focused Equity ETF AdvisorShares Trust | 3.51 % | as of Mar 31, 2026 ↗ |
| The Jensen Quality Growth Fund Inc The Jensen Quality Growth Fund Inc. | 3.43 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 997 | +17 | 532,879,094 | -4.6 % |
| 2026Q1 | 980 | -73 | 558,623,456 | +0.9 % |
| 2025Q4 | 1,053 | -43 | 553,660,914 | -1.5 % |
| 2025Q3 | 1,096 | +14 | 562,311,264 | -0.8 % |
| 2025Q2 | 1,082 | +111 | 566,661,591 | +3.0 % |
| 2025Q1 | 971 | -30 | 550,271,440 | +2.0 % |
| 2024Q4 | 1,001 | +25 | 539,528,284 | -0.2 % |
| 2024Q3 | 976 | -18 | 540,562,323 | -2.8 % |
| 2024Q2 | 994 | -16 | 556,102,059 | +6.8 % |
| 2024Q1 | 1,010 | -58 | 520,736,580 | -5.4 % |
| 2023Q4 | 1,068 | 550,206,490 |
Institutional managers
3,058 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 145,687,458 | 15B $ | as of Mar 31, 2026 |
| STATE STREET CORP | 79,575,468 | 8.2B $ | as of Mar 31, 2026 |
| Capital Research Global Investors | 49,775,362 | 5.1B $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 45,500,055 | 4.7B $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 39,148,795 | 4B $ | as of Mar 31, 2026 |
| Capital International Investors | 37,498,227 | 3.8B $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 30,101,596 | 3.1B $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 27,070,518 | 2.8B $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 26,767,099 | 2.7B $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 20,022,905 | 2.1B $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 19,394,974 | 2B $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 19,279,608 | 2B $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 17,277,212 | 1.8M $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 15,909,341 | 1.6B $ | as of Mar 31, 2026 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 15,499,870 | 1.6B $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 14,505,201 | 1.5B $ | as of Mar 31, 2026 |
| AMERIPRISE FINANCIAL INC | 14,119,549 | 1.4B $ | as of Mar 31, 2026 |
| DEUTSCHE BANK AG\ | 14,091,704 | 1.4B $ | as of Mar 31, 2026 |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 13,587,118 | 1.4B $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 13,198,740 | 1.4B $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 12,442,717 | 1.3B $ | as of Mar 31, 2026 |
| Legal & General Group Plc | 12,285,529 | 1.3B $ | as of Mar 31, 2026 |
| UBS Group AG | 12,152,765 | 1.2B $ | as of Mar 31, 2026 |
| Nuveen, LLC | 11,191,853 | 1.1B $ | as of Mar 31, 2026 |
| FMR LLC | 10,845,315 | 1.1B $ | as of Mar 31, 2026 |
Declared shareholders of Abbott Laboratories
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vanguard Capital Management | 7.50 % | 130,676,776 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Abbott Laboratories
421 funds declare 1,127 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Fund shareholders of Abbott Laboratories". https://titelia.com/en/stocks/abbott-laboratories-US0028241000